Navigation Links
Herceptin May Boost Long-Term Survival After Aggressive Breast Cancer
Date:2/25/2011

By Maureen Salamon
HealthDay Reporter

THURSDAY, Feb. 24 (HealthDay News) -- The cancer drug Herceptin produces significantly longer disease-free survival in women with an aggressive type of early-stage breast cancer who take the drug for a year after standard chemotherapy, a new study suggests.

After analyzing more than 5,000 women from 39 countries between December 2001 and June 2005, Herceptin appeared to reduce the likelihood of a cancer recurrence by 24 percent, the Italian researchers said.

Herceptin (trastuzumab) is a monoclonal antibody that suppresses the HER2/neu protein, which fuels 20 percent to 30 percent of breast cancers. These so-called HER2-positive cancers tend to be aggressive and fast-growing.

"We were inclined to consider the possibility that long-term exposure to trastuzumab deserved a proper test and might be useful," said study author Dr. Luca Gianni, a researcher at Fondazione San Raffaele in Milan.

But while Herceptin patients in the four-year study experienced longer disease-free survival times than patients in an observation group taking chemotherapy alone, the overall risk of death was similar between the two groups.

Gianni attributed this to the fact that 52 percent of patients from the observation group crossed over to receive Herceptin treatment midway through the research because of the drug's impressive early results.

The study received funding from Hoffman-La Roche, the maker of Herceptin, and is published in the Feb. 25 issue of The Lancet Oncology.

"It is very difficult to account for the bias introduced by the late introduction of trastuzumab in more than half of the patients originally randomized to no therapy," Gianni said. "However, it is reasonable to think that the lack of a measurable improvement of survival in the current analysis was due to the effect of the introduction of trastuzumab therapy in a large proportion of women who selecte
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Herceptin and Tykerb effective against a subset of gastric cancers
2. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
3. MiRNA-21 linked to tumor suppressor loss, herceptin resistance
4. Drug now used to treat erectile dysfuncton may enhance delivery of herceptin to certain brain tumors
5. Erythropoietin counteracts breast cancer treatment with herceptin
6. Global Nutrition Firm Takes Dose of SonicWALL to Boost Network Health
7. Aspirin May Boost Breast Cancer Survival
8. A midday nap markedly boosts the brains learning capacity
9. CustomerCentric Selling Helps BCC Software Dramatically Boost Sales Performance and Produce Record Results
10. Dry Weather Boosts Odds of Flu Outbreaks
11. Fitness Boosts Brain Power in Multiple Sclerosis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Herceptin May Boost Long-Term Survival After Aggressive Breast Cancer
(Date:6/18/2013)... (PRWEB) June 18, 2013 Parker ... protecting the rights of victims injured by defective medical ... review of Medtronic’s Infuse bone graft products are now ... a medical journal, the two studies serve up two ... effectiveness” when comparing Infuse and the traditional bone graft; ...
(Date:6/18/2013)... Senior drug regulatory officials from mainland China and Taiwan will ... time in the U.S.—the need for more collaboration between the ... a timely manner. Representatives from the Taiwan and mainland China ... processes in drug review during the Convergence in Regulatory ... 2013 49th Annual Meeting . , While mainland ...
(Date:6/18/2013)... ENT and Allergy Associates, LLP (ENTA) ... the opposite. , New York/New Jersey’s premier ear, ... trained physicians offering superior healthcare to children and adults ... Greater New York area-only considers adding to its current ... that includes the right communities to serve, the right ...
(Date:6/18/2013)... June 18, 2013 Palo Alto has taken ... America's greenest cities with its recent major long-term solar power ... three major solar electric power purchase agreements , which together ... (MWh) of solar photovoltaic electric power per year, which is ... needs. That’s enough power to supply all 65,000+ Palo ...
(Date:6/18/2013)... Biomet hip lawsuit claims ... in a multidistrict litigation in U.S. District Court, Northern ... to court records, the litigation’s most recent status conference ... Court also convened a motions hearing and a tutorial ... Biomet hip replacement litigation. The proceeding’s next Status ...
Breaking Medicine News(10 mins):Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 2Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 3Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 4Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 5Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3
... Linkage between the two might be genetic, researchers say , , ... history of melanoma are twice as likely to develop Parkinson,s ... this association are not clear, other studies have shown that ... melanoma. , "For people with a family member with melanoma, ...
... PHILADELPHIA, Feb. 16 Elderly patients who undergo ... than at nonteaching hospitals, but these better survival ... patients. "We found an advantage in surgical outcomes ... hospitals, as we had expected from other studies," ...
... more from improved expertise after surgery, but reasons unclear, ... White patients are less likely to die of post-surgery ... that benefit doesn,t apply to black patients, a U.S. ... Outcomes Research at The Children,s Hospital of Philadelphia and ...
... for technological breakthroughsCLEVELAND, Feb. 16 NorTech, in ... pleased to announce the winners of its annual ... of Northeast Ohio innovators who are impacting the ... the world. This year, a distinguished panel of ...
... victimized as recessions occur, study shows , , MONDAY, Feb. ... certain minority groups suffer at the hands of criminals ... National crime statistics from 1973 to 2005 show ... Latinos during and after periods of recession, according to ...
... twins were conjoined from the breast bone to the ... pediatricians and nurses at Children,s Hospital of Pittsburgh of ... procedure.The 2-year-old twin girls -- Dagian and Danielle Lee, ... began at 6:30 a.m. Saturday, Dec. 13, 2008, and ...
Cached Medicine News:Health News:Family History of Melanoma Doubles Parkinson's Risk 2Health News:White Patients Benefit More Than Blacks in Surviving Surgical Complications at Teaching Hospitals 2Health News:White Patients Benefit More Than Blacks in Surviving Surgical Complications at Teaching Hospitals 3Health News:Teaching Hospitals' Post-Op Gains Not Extended to Blacks 2Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 2Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 3Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 4Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 5Health News:Conjoined Twins Separated by Surgical Team at Children's Hospital of Pittsburgh of UPMC During Complex, 24-Hour Procedure 2
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... public offering of common shares (the "Offering"). Pursuant to ... at a price of $85.00 per share, for aggregate ... file a final prospectus supplement to its effective shelf ... similar filing with the securities regulatory authorities in each ...
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
(Date:6/18/2013)... N.J. , June 18, 2013  Actavis, Inc. (NYSE: ... Actavis") has filed with the U.S. Securities and Exchange Commission ... Actavis, proposed acquisition of Warner Chilcott plc (NASDAQ: ... of Actavis and Warner Chilcott (the "Form S-4"). ... and Warner Chilcott have entered into a definitive ...
Breaking Medicine Technology:Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4Three-in-One X3130 Appliance Inlet Module 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7
... 2011  IRIDEX Corporation (Nasdaq: IRIX ) today ... 10 years demonstrates the safety and efficacy of MicroPulse ... the retina tissue damage associated with conventional laser therapy.  ... and Prevention, DME, a swelling of retinal tissue, is ...
... Reportlinker.com announces that a new market ... Global Medical Ultrasound ... http://www.reportlinker.com/p098401/Global-Medical-Ultrasound-Equipment-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_I This report analyzes ... in US$ Million by the following End-Use ...
Cached Medicine Technology:10-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema 210-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema 3Global Medical Ultrasound Equipment Industry 2Global Medical Ultrasound Equipment Industry 3Global Medical Ultrasound Equipment Industry 4Global Medical Ultrasound Equipment Industry 5Global Medical Ultrasound Equipment Industry 6Global Medical Ultrasound Equipment Industry 7Global Medical Ultrasound Equipment Industry 8Global Medical Ultrasound Equipment Industry 9Global Medical Ultrasound Equipment Industry 10Global Medical Ultrasound Equipment Industry 11Global Medical Ultrasound Equipment Industry 12Global Medical Ultrasound Equipment Industry 13Global Medical Ultrasound Equipment Industry 14Global Medical Ultrasound Equipment Industry 15Global Medical Ultrasound Equipment Industry 16Global Medical Ultrasound Equipment Industry 17Global Medical Ultrasound Equipment Industry 18Global Medical Ultrasound Equipment Industry 19Global Medical Ultrasound Equipment Industry 20Global Medical Ultrasound Equipment Industry 21Global Medical Ultrasound Equipment Industry 22Global Medical Ultrasound Equipment Industry 23Global Medical Ultrasound Equipment Industry 24Global Medical Ultrasound Equipment Industry 25
... Boston Scoliosis Brace is the proven system ... For Orthotists unfamiliar with the system, BBI ... in Avon, Massachusetts. ,The Boston Scoliosis Brace ... or 15 degrees lordosis, as well as ...
... The Back/Hip/Rib Cryo/Cuff combines the therapeutic benefits ... and cold to minimize pain. ,The versatile cuff ... the back, hip, or rib area. A support ... back support and can be easily removed if ...
... a modular functional lumbar support for ... the lumbosacral transition. Its modular design ... individually adaptable multi-stage regimen.,Stage 1 (Stabilization ... stabilization of vertebral body segments S1 ...
... support and stability to help relieve low back ... body contours for a cool, comfortable, custom fit. ... provide extra-firm support to the spine. Wide ... to the low back - easily accessed and ...
Medicine Products: